ibt - immunological & biochemical testsystems GmbH Company Profile

17:50 EDT 26th September 2017 | BioPortfolio

ibt - immunological and biochemical testsystems GmbH is a company dedicated to supply the scientific community with reagents and assays. Our reagents are recombinant proteins (viral and bacterial antigens, cytokines and chemokines, growth factors, hormones, transcription factors, tumor markers, enzymes and others) and polyclonal and monoclonal antibodies. Our main interest is in insulin-like growth factors (IGF´s) and insulin-like growth factor binding proteins (IGFBP´s) and related molecules. Our research ist dedicated to the development of assay systems for the detection of functional proteins based on ligand technologies.




Phone: +49 7121 51463 4
Fax: 49 7121 514 635

News Articles [326 Associated News Articles listed on BioPortfolio]

FDA approves BD’s new immunological diagnostic system

Becton, Dickinson and Company (BD) has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its new immunological diagnostic system.

Abnormal Liver Biochemical Tests in Hyperthyroidism

How often do patients with newly diagnosed thyrotoxicosis develop liver biochemical abnormalities? What are the risk factors? Clinical Endocrinology

EC approves Sandoz’s Rixathon for blood cancer and immunological diseases

Novartis division Sandoz’s Rixathon (biosimilar rituximab) has received approval from the European Commission (EC) to treat blood cancers and immunological diseases in Europe.

Biochemical "fingerprints" reveal diabetes progression

Researchers from Umeå University in Sweden describe a new method to study biochemical changes that occur in the pancreas during the development of diabetes. The method, recently published in Scientif...

Stada bündelt Vertriebsgesellschaften in Deutschland

FRANKFURT (Dow Jones)--Der Arzneimittelkonzern Stada bündelt seine Geschäftsaktivitäten in Deutschland. Die bisher vier Vertriebsgesellschaften Stadavita GmbH, Stada GmbH, cell pharm GmbH und Stad....

Lilly and Nektar partner to develop new immunological therapy NKTR-358

Eli Lilly and Company has entered a strategic collaboration to co-develop Nektar Therapeutics’ new immunological therapy NKTR-358.

CDMO Ardena Acquires Analytical Biochemical Laboratory

NewsABL acquisition extends Ardena’s early-phase offering.

Sandoz gets EC nod for Rixathon to treat blood cancers and immunological diseases

Novartis subsidiary Sandoz has secured approval from the European Commission (EC) for its Rixathon (biosimilar rituximab) to treat blood cancers and immunological diseases.

PubMed Articles [740 Associated PubMed Articles listed on BioPortfolio]

Novel Treatment Strategies for Primary Biliary Cholangitis.

Despite the presumed immunological pathogenesis of primary biliary cholangitis, no clear or even harmful consequences have resulted from treatments designed to modify the immunological condition. Urso...

Analysis of immune-biochemical indicators to assess the risk of developing cardiological pathology.

Prognostic immuno-biochemical tests to assess the severity of the condition of patients with cardiac diseases were developed. A comparative analysis of clinical and laboratory blood parameters, which ...


This study evaluated the activity of leaf essential oil (EO) from Hyptis mutabilis as well as its major constituent, (-)-globulol, in infections by the parasite Ichthyophthirius multifiliis (ich). Eff...

Redirecting the focus of cancer immunotherapy to premalignant conditions.

Much progress has been made in introducing immunological treatment approaches for cancer, with lessons learned from both the successes and failures of immunotherapy. Among the challenges of immunother...

Evaluation of dietary Hybanthus enneaspermus (Linn F. Muell.) as a growth and haemato-immunological modulator in Labeo rohita.

This study evaluated the effects of Hybanthus enneaspermus aqueous extract (HEE) as a feed supplement on growth, immune responses, haematological, and biochemical parameters of Labeo rohita and its su...

Clinical Trials [1032 Associated Clinical Trials listed on BioPortfolio]

Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort

This is an open-label study of patients with relapsing forms of Multiple Sclerosis designed to assess the biochemical, immunological and pharmacokinetic profiles of a large, actively infu...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

The primary objective of the trial is to assess the ability of an early and intermittent antiretroviral therapy in maintaining an immunological stability in antiretroviral naive HIV infect...

Fish OIL Optimal dosE Determination Study

The primary objective of this trial is to determine the safety and efficacy of IV fish oil doses of 0.20 g/kg and 0.50 g/kg, compared to a control group, in critically ill patients with se...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [712 Associated Companies listed on BioPortfolio]

ibt - immunological & biochemical testsystems GmbH

ibt - immunological and biochemical testsystems GmbH is a company dedicated to supply the scientific community with reagents and assays. Our reagents are recombinant proteins (viral and bacterial ant...


Lorantis is discovering and developing breakthrough products for the selective treatment of immunological and inflammatory diseases based on immune regulation: the induction of antigen-specific tolera...

EY Laboratories inc

Manufacturer of biochemical reagents serving the needs of biochemical research in glycobiology, immunology, and microbiology. Manufacturer of rapid, simple, and stable diagnostic test kits for visual ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

The Biotech Source Incorporated

The Biotech Source, has been supplying bulk immunological and biological products to the Human, Animal, Environmental, Plant and other immunological diagnostic industries. Diagnostic kit manufacturers...

More Information about "ibt - immunological & biochemical testsystems GmbH" on BioPortfolio

We have published hundreds of ibt - immunological & biochemical testsystems GmbH news stories on BioPortfolio along with dozens of ibt - immunological & biochemical testsystems GmbH Clinical Trials and PubMed Articles about ibt - immunological & biochemical testsystems GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ibt - immunological & biochemical testsystems GmbH Companies in our database. You can also find out about relevant ibt - immunological & biochemical testsystems GmbH Drugs and Medications on this site too.

Quick Search

Relevant Topic

An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Corporate Database Quicklinks

Searches Linking to this Company Record